CHIP-/--Mouse Liver: Adiponectin- AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kim, Sung Mi ^a   Grenert, James P ^a,b   Patterson, Cam ^c   Correia, Maria Almira ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, MOUSE; ADIPONECTIN RECEPTOR 2, MOUSE; AMPK ALPHA1 SUBUNIT, MOUSE; CYTOCHROME P-450 2E1, MOUSE; CYTOCHROME P450 2E1; FORKHEAD TRANSCRIPTION FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE 1; STUB1 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ANIMAL; CELL CULTURE; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; MOUSE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; UBIQUITINATION;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELLS, CULTURED; CYTOCHROME P-450 CYP2E1; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; LIVER; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 8; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTORS, ADIPONECTIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84978388409     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29423     Document Type: Article

References (71)

1. Ballinger, C. A. et al. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 19, 4535-4545 (1999).
2. Morishima, Y. et al. Regulation of cytochrome P450 2E1 by heat shock protein 90-dependent stabilization and CHIP-dependent proteasomal degradation. Biochemistry 44, 16333-16340 (2005).
3. Wang, Y. et al. Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: identification of sites targeted for phosphorylation and ubiquitination. J Biol Chem 286, 9443-9456 (2011).
4. Kim, S. M., Acharya, P., Engel, J. C. & Correia, M. A. Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance. J Biol Chem 285, 35866-35877 (2010).
5. Wang, Y. et al. Human liver cytochrome P450 3A4 ubiquitination: molecular recognition by UBC7-gp78 autocrine motility factor receptor and UbcH5a-CHIP-Hsc70-Hsp40 E2-E3 ubiquitin ligase complexes. J Biol Chem 290, 3308-3332 (2015).
6. Guengerich, F. P. Human cytochrome P450 enzymes in Cytochrome P450: Structure, Mechanism and Biochemistry (ed. Ortiz de Montellano, P.) 523-785 (Springer International Publishing, 2015).
7. Leclercq, I. A. et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105, 1067-1075 (2000).
8. Cederbaum, A. I., Lu, Y., Wang, X. & Wu, D. Synergistic toxic interactions between CYP2E1, LPS/TNFalpha, and JNK/p38 MAP kinase and their implications in alcohol-induced liver injury. Adv Exp Med Biol 815, 145-172 (2015).
9. Bardag-Gorce, F. et al. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp Mol Pathol 81, 191-201 (2006).
10. Cederbaum, A. I., Yang, L., Wang, X. & Wu, D. CYP2E1 Sensitizes the Liver to LPS- and TNF alpha-Induced Toxicity via Elevated Oxidative and Nitrosative Stress and Activation of ASK-1 and JNK Mitogen-Activated Kinases. Int J Hepatol 2012, 582790-9-582809 (2012).
11. Schattenberg, J. M. & Czaja, M. J. Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling. Redox Biol 3, 7-15 (2014).
12. Tierney, D. J., Haas, A. L. & Koop, D. R. Degradation of cytochrome P450 2E1: selective loss after labilization of the enzyme. Arch Biochem Biophys 293, 9-16 (1992).
13. Wu, D. & Cederbaum, A. I. Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK. Redox Biol 1, 552-565 (2013).
14. Min, J. N. et al. CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol Cell Biol 28, 4018-4025 (2008).
15. Zhang, C., Xu, Z., He, X. R., Michael, L. H. & Patterson, C. CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 288, H2836-H2842 (2005).
16. Gorsky, L. D., Koop, D. R. & Coon, M. J. On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. Products of oxygen reduction. J Biol Chem 259, 6812-6817 (1984).
17. Ingelman-Sundberg, M. & Johansson, I. Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. J Biol Chem 259, 6447-6458 (1984).
18. Greer, E. L. et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 282, 30107-30119 (2007).
19. Tsuchida, A. et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279, 30817-30822 (2004).
20. van der Horst, A. & Burgering, B. M. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8, 440-450 (2007).
21. de Keizer, P. L., Burgering, B. M. & Dansen, T. B. Forkhead box o as a sensor, mediator, and regulator of redox signaling. Antioxid Redox Signal 14, 1093-1106 (2011).
22. Tikhanovich, I., Cox, J. & Weinman, S. A. Forkhead box class O transcription factors in liver function and disease. J Gastroenterol Hepatol 28 Suppl 1, 125-131 (2013).
23. Webb, A. E. & Brunet, A. FOXO transcription factors: key regulators of cellular quality control. Trends Biochem Sci 39, 159-169 (2014).
24. Takaki, A., Kawai, D. & Yamamoto, K. Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci 15, 7352-7379 (2014).
25. Handa, P. et al. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis. Hepatology 60, 133-145 (2014).
26. Ariz, U., Mato, J. M., Lu, S. C. & Martinez Chantar, M. L. Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new? Methods Mol Biol 593, 109-136 (2010).
27. Maher, J. J. New insights from rodent models of fatty liver disease. Antioxid Redox Signal 15, 535-550 (2011).
28. Jiang, J. et al. A mitochondria-targeted triphenylphosphonium-conjugated nitroxide functions as a radioprotector/mitigator. Radiat Res 172, 706-717 (2009).
29. Weston, C. R. & Davis, R. J. The JNK signal transduction pathway. Curr Opin Genet Dev 12, 14-21 (2002).
30. Czaja, M. J. JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab 21, 707-713 (2010).
31. Seki, E., Brenner, D. A. & Karin, M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 143, 307-320 (2012).
32. Farrell, G. C., van Rooyen, D., Gan, L. & Chitturi, S. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver 6, 149-171 (2012).
33. Duwaerts, C. C. & Maher, J. J. Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis. Curr Hepatol Rep 13, 119-129 (2014).
34. Noureddin, M., Mato, J. M. & Lu, S. C. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Exp Biol Med (Maywood) 240, 809-820 (2015).
35. Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13, 251-262 (2012).
36. Manning, B. D. & Cantley, L. C. AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274 (2007).
37. Zhang, J. Y. et al. The JNK/AP1/ATF2 pathway is involved in H2O2-induced acetylcholinesterase expression during apoptosis. Cell Mol Life Sci 65, 1435-1445 (2008).
38. Lau, E. & Ronai, Z. A. ATF2 - at the crossroad of nuclear and cytosolic functions. J Cell Sci 125, 2815-2824 (2012).
39. Yu, T. et al. The regulatory role of activating transcription factor 2 in inflammation. Mediators Inflamm 2014, 950472-950479 (2014).
40. Takaishi, K., Duplomb, L., Wang, M. Y., Li, J. & Unger, R. H. Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. Proc Natl Acad Sci USA 101, 7106-7111 (2004).
41. Liu, H., Lo, C. R. & Czaja, M. J. NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 35, 772-778 (2002).
42. Wree, A. et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59, 898-910 (2014).
43. Sahai, A. et al. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium. Am J Physiol Gastrointest Liver Physiol 291, G55-G62 (2006).
44. Gunawan, B. K. et al. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 131, 165-178 (2006).
45. Yung, H. W., Charnock-Jones, D. S. & Burton, G. J. Regulation of AKT phosphorylation at Ser473 and Thr308 by endoplasmic reticulum stress modulates substrate specificity in a severity dependent manner. PLoS One 6, e17894- (2011).
46. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. & Hemmings, B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 (1995).
47. Merrill, G. F., Kurth, E. J., Hardie, D. G. & Winder, W. W. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273, E1107-E1112 (1997).
48. Li, F. et al. C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitinmediated degradation of FoxO1. J Biol Chem 284, 20090-20098 (2009).
49. Barthel, A., Schmoll, D., Kruger, K. D., Roth, R. A. & Joost, H. G. Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 143, 3183-3186 (2002).
50. Jager, S., Handschin, C., St-Pierre, J. & Spiegelman, B. M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA 104, 12017-12022 (2007).
51. Xiong, X., Tao, R., DePinho, R. A. & Dong, X. C. The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism. J Biol Chem 287, 39107-39114 (2012).
52. Kamei, Y. et al. A forkhead transcription factor FKHR up-regulates lipoprotein lipase expression in skeletal muscle. FEBS Lett 536, 232-236 (2003).
53. Liu, H., Jones, B. E., Bradham, C. & Czaja, M. J. Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Junmediated cell death from TNF-alpha. Am J Physiol Gastrointest Liver Physiol 282, G257-G266 (2002).
54. Wang, X., Wu, D., Yang, L. & Cederbaum, A. I. Hepatotoxicity mediated by pyrazole (cytochrome P450 2E1) plus tumor necrosis factor alpha treatment occurs in c-Jun N-terminal kinase 2-/- but not in c-Jun N-terminal kinase 1-/- mice. Hepatology 54, 1753-1766 (2011).
55. Schattenberg, J. M. et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43, 163-172 (2006).
56. Hwang, J. R., Zhang, C. & Patterson, C. C-terminus of heat shock protein 70-interacting protein facilitates degradation of apoptosis signal-regulating kinase 1 and inhibits apoptosis signal-regulating kinase 1-dependent apoptosis. Cell Stress Chaperones 10, 147-156 (2005).
57. Nadeau, P. J., Charette, S. J., Toledano, M. B. & Landry, J. Disulfide Bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H(2)O(2)-induced c-Jun NH(2)-terminal kinase activation and apoptosis. Mol Biol Cell 18, 3903-3913 (2007).
58. Aguirre, V., Uchida, T., Yenush, L., Davis, R. & White, M. F. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275, 9047-9054 (2000).
59. Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (2002).
60. Gaude, H. et al. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1. Oncogene 31, 1582-1591 (2012).
61. Schisler, J. C. et al. CHIP protects against cardiac pressure overload through regulation of AMPK. J Clin Invest 123, 3588-3599 (2013).
62. Arad, M., Seidman, C. E. & Seidman, J. G. AMP-activated protein kinase in the heart: role during health and disease. Circ Res 100, 474-488 (2007).
63. Ronnebaum, S. M., Patterson, C. & Schisler, J. C. Minireview: hey U(PS): metabolic and proteolytic homeostasis linked via AMPK and the ubiquitin proteasome system. Mol Endocrinol 28, 1602-1615 (2015).
64. Iwabu, M. et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464, 1313-1319 (2010).
65. Yamauchi, T. et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288-1295 (2002).
66. Yamauchi, T. et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13, 332-339 (2007).
67. Essers, M. A. et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. Embo J 23, 4802-4812 (2004).
68. Okada-Iwabu, M. et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503, 493-499 (2013).
69. Hardie, D. G. Regulation of AMP-activated protein kinase by natural and synthetic activators. Acta Pharm Sin B. 6, 1-19 (2016).
70. Meagher, E. A. & FitzGerald, G. A. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 28, 1745-1750 (2000).
71. Juvekar, A. et al. Electrophoretic mobility shift assay analysis of NFkappaB transcriptional regulation by nuclear IkappaBalpha. Methods Mol Biol 809, 49-62 (2012).